Figure 1
Figure 1. Changes in BM disease burden versus serum IgM levels at 6 months following treatment with Everolimus.

Changes in BM disease burden versus serum IgM levels at 6 months following treatment with Everolimus.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal